[Global.net report reporter Kang Bohao] The epidemic in Taiwan continues to spread, the DPP authorities are slow in purchasing vaccines and various reasons have led to a shortage of vaccines on the island. The Taiwan authorities have high hopes for vaccines produced in Taiwan, but their actual efficacy and safety are affected by the island. Widely questioned.
According to the "United Daily News", Taiwan Union Biotech announced on the 27th that it had successfully solved the second phase of blindness, and then contacted the previous "high-end" vaccine. There are three coincidences on the road to the development of Taiwan-made vaccines, which makes people feel weird and cited. People continue to associate.
According to reports, first of all, Lianya Biotech also chose to announce the results of blindness removal on Sunday. Same as "high-end", it announced good news on Sunday, but did not discuss the issue of protection. Its actual effect against the new crown virus and its mutant virus. Doubtful.
The people on the island are even more worried about these two vaccines. Global pharmaceutical companies will fail when they achieve the third phase. There are many people, but Taiwan has to use immature vaccines to fight against the "changes every day" of the new crown. Virus, when Pfizer, AstraZeneca, etc. have injected hundreds of millions of vaccines in the world, who wants to be the white rat that produces vaccines?
According to the report, secondly, before that, the stock prices of the two companies had risen sharply before the blind was resolved. The high-end price rose from NT$80 per share to NT$400. Later, after the blind was resolved, the stock price went up all the way. It has fallen to NT$269.5, while the company’s subsidiary of the Uniasia Biotechnology Group has not yet officially launched, so it has soared six or seven times.
Taiwan’s foreign affairs department, the Paraguayan government, and the U.S. affiliates of Uniasia also announced that they would purchase one million doses of press releases once Uniasia obtained Taiwan’s emergency authorization. This incident also caused great dissatisfaction among Paraguayan citizens and questioned why the government wanted to buy this unfinished three. Vaccines to be tested in the future.
However, Lianya's share price has already risen sharply.
In the volatility of stock prices, various rumors, such as stock speculation, have also continued to spread.
The report mentioned that thirdly, the two companies are inseparable from the United States in their development process. The "high-end" is to license the US National Institutes of Health to obtain technology. Currently, they are still acquiring the original technology of the new crown virus. Variant viruses require more authorization.
The authorization is to pay a fee, and this amount is always a trade secret and has not been disclosed.
The link between UniAsia and the United States seems to be greater. The report cited Reuters news. There are many international controversies. The private security company Blackwater International, founder Eric Princes, entered a US company "COVAXX" vaccine at the end of last year. The vaccine code-name developed by "COVAXX" is (UB-612), and this company is a new company established last year by Wang Changyi, the founder of Uniasia Biotech.
The report finally mentioned that Taiwan does need to have its own vaccine production capacity so that it will not be controlled by others in the future, but the above three coincidences are worrying and will cast a shadow on the development of Taiwan-made vaccines.
According to previous reports, Taiwan’s “self-produced vaccine review committee” Chen Peizhe, who had been accused of being “green to juice”, resigned and slapped the DPP authorities. According to Taiwan’s “Lianhe Bao” on the 8th, Tsai Ing-wen proposed the first wave on May 13 The self-produced vaccine is expected to be available at the end of July, causing Chen Peizhe's concerns.
In an interview with Taiwanese media on the 5th, he said that the strategy for developing vaccines in most regions is to spread risks, but “the DPP just doesn’t believe in science”; “high-end” and Lianya specialize in inactivated vaccines, but this time they are doing it. The protein subunit vaccine "is basically to let the chef of the Chinese restaurant change French cuisine."
He bluntly stated that if according to the standards of the World Health Organization, it is absolutely impossible for a self-produced vaccine to pass the EUA (Emergency Use Authorization) in July.
Pro-green famous mouth Zhou Yukou immediately broke the news that Chen Peizhe, as a member of the Expert Meeting on Evaluation Methods of Self-produced Vaccine Efficacy of the Food and Drug Administration of the Ministry of Health and Welfare, violated review ethics and attacked self-produced vaccines. He resigned as a review member on June 6. .
In this regard, Chen Peizhe retorted on the 7th, saying that he had resigned as early as the end of May, and only then began to accept interviews, abiding by professional ethics.
As for the reason for his resignation, he said that Tsai Ing-wen had already stated that the self-produced vaccine was launched at the end of July. "How can the Food and Drug Administration block the pressure of the President? It is difficult for the review committee to maintain its independence."
Chen Peizhe said that in order to maintain objectivity and impartiality, the "Food and Drug Administration" will not publish the list of vaccine review committees, but why someone got the list and broke the news that he asked to resign. The motive behind it is worth investigating, "This is a slander, I Do not regret telling the truth".